$CVV Cashflow Statement | Understand Stock

$CVV

$4.05 +$0.14 (3.58%) Close

$CVV Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Segment net income (loss)
Adjustments to reconcile net loss to net cash used in operating activities:
Gain on sale of building
Gain on debt extinguishment
Stock-based compensation
Depreciation and amortization
Provision for excess and obsolete inventory
Provision (recovery) for bad debt
Impairment
Gains on sales of equipment
Loss on disposition of Tantaline
Changes in operating assets and liabilities
Accounts receivable
Contract assets
Inventories
Income tax receivable
Employee retention credit receivable
Other assets
Accounts payable
Accrued expenses
Contract liabilities
Total adjustments

Net cash used in operating activities
Cash flows from investing activities:
Net proceeds from sale of building
Purchase of property and equipment
Capitalized patent costs
Net proceeds from sale of assets
Investment in captive insurance company
Net proceeds from sales of equipment
Net cash used in disposition of Tantaline
Deposits from purchaser of MesoScribe assets

Net cash (used in) provided by investing activities
Cash flows from financing activities:
Payments of long-term debt
Proceeds from exercise of stock options
Net cash used in financing activities
Net decrease in cash and cash equivalents
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year
Supplemental disclosure of cash flow information:
Income taxes paid
Interest paid
Non-cash investing and financing activities:
Loan obtained for new equipment
Property, plant and equipment transferred to assets held for sale
Inventory transferred to property, plant and equipment

Comments